Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading Up 4.9% – Still a Buy?

Posted by Adam Masters on Dec 19th, 2024

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report) shares shot up 4.9% on Tuesday . The stock traded as high as $16.60 and last traded at $16.60. 664 shares changed hands during trading, a decline of 97% from the average session volume of 19,786 shares. The stock had previously closed at $15.82.

Analyst Upgrades and Downgrades

TLX has been the topic of several recent research reports. William Blair upgraded Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th. UBS Group began coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Friday, November 15th. They issued a “buy” rating and a $21.00 target price for the company.

Read Our Latest Research Report on TLX

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

About Telix Pharmaceuticals Limited American Depositary Shares

(Get Free Report)

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.